Peptide therapy is one of the fastest-growing opportunities in cash-pay medicine. With the expected FDA reclassification of approximately 14 peptides from Category 2 back to Category 1, medical practices across the country are preparing to launch or expand peptide therapy programs.
This guide covers everything a medical practice needs to know to start offering peptide therapy, from choosing the right peptides and pharmacy partners to building clinical workflows and marketing your program to patients.
Why Peptide Therapy Is an Opportunity Right Now
Three forces are converging to make 2026 the optimal time for practices to launch peptide programs.
Regulatory momentum. In February 2026, HHS Secretary RFK Jr. announced that approximately 14 peptides currently classified as Category 2 are expected to return to Category 1, making them eligible for compounding. While the formal rule is still pending, the signal is clear and practices that prepare now will be first to market.
Patient demand is growing. Patient awareness of peptides like BPC-157, CJC-1295/Ipamorelin, and Thymosin Alpha-1 has grown significantly. Functional medicine, anti-aging, and wellness communities have driven demand even during the Category 2 restrictions. Practices that can offer these therapies will capture patients who are actively searching.
GLP-1 compounding restrictions create diversification urgency. The FDA ended the semaglutide shortage in February 2025 and is restricting compounded GLP-1 medications. Practices dependent on compounded semaglutide or tirzepatide need additional revenue streams. Peptide therapy provides a complementary cash-pay program that is not subject to the same compounding restrictions.
The Economics
Peptide therapy programs operate on a cash-pay model with strong margins. Practices typically purchase compounded peptides at wholesale pricing from their pharmacy partner and set their own patient pricing. Unlike insurance-based services, there are no claim denials, prior authorizations, or reimbursement delays.
A single peptide therapy patient on a monthly protocol generates recurring revenue. Practices offering multiple peptides across therapeutic categories (tissue repair, immune support, body composition, cognitive function) can serve a wide range of patient needs from the same program infrastructure.
Which Peptides Practices Are Offering
The most commonly prescribed peptides fall into several therapeutic categories. Here are the peptides that practices are building programs around:
Tissue Repair and Recovery
BPC-157 is the most widely requested peptide in practice settings. It supports tissue repair, gut health, and musculoskeletal recovery. Patients seeking BPC-157 include athletes recovering from injuries, patients with GI issues, and people dealing with chronic musculoskeletal pain.
TB-500 (Thymosin Beta-4) supports wound healing, tissue repair, and inflammation reduction. It is often used alongside BPC-157 in recovery protocols.
Growth Hormone Support
CJC-1295/Ipamorelin is one of the most popular peptide combinations. CJC-1295 stimulates growth hormone releasing hormone, while Ipamorelin stimulates growth hormone release. Together, they support body composition, recovery, sleep quality, and anti-aging. This combination is a staple in most peptide therapy programs.
AOD-9604 is a growth hormone fragment focused on fat metabolism and body composition. It appeals to patients interested in weight management without the broader hormonal effects of full growth hormone protocols.
Immune Support
Thymosin Alpha-1 is a naturally occurring peptide involved in immune system modulation. It supports immune function in patients with chronic infections, autoimmune conditions, or general immune system optimization. It is particularly popular in functional medicine practices.
Skin and Wellness
GHK-Cu is a copper peptide that supports skin health, wound healing, and collagen production. It is popular in anti-aging and aesthetic medicine practices.
Cognitive and Neurological
Selank and Semax are neuropeptides used for cognitive function and neuroprotection. They are less commonly prescribed than the peptides listed above but represent a growing category in longevity-focused practices.
Choosing a Compounding Pharmacy Partner
Your pharmacy partner is one of the most critical decisions for a peptide therapy program. The right partner ensures reliable supply, competitive pricing, quality assurance, and smooth fulfillment.
Key Evaluation Criteria
Peptide formulary breadth. Does the pharmacy carry the specific peptides you want to prescribe? Some pharmacies have extensive peptide formularies while others focus on a narrower selection. Make sure your priority peptides are available.
503A vs. 503B pathway. 503A pharmacies compound patient-specific prescriptions based on individual orders. 503B outsourcing facilities can compound in larger batches. Both pathways are used for peptide therapy. Consider which aligns with your prescribing volume and workflow.
Fulfillment model. Some pharmacies ship directly to patients. Others ship to the practice for dispensing. Direct-to-patient fulfillment is more convenient and reduces practice overhead. Make sure the model works for your operations.
Quality and accreditation. Look for pharmacies with PCAB accreditation, proper state licensing, and documented quality testing protocols. For peptides, third-party potency and purity testing is especially important.
Integration capabilities. Can you send prescriptions electronically with minimal manual work? Platforms like Karpa Health integrate directly with multiple pharmacies for one-click prescribing, eliminating manual faxing or portal entry.
Pharmacy Partners to Consider
Several compounding pharmacies have established peptide formularies:
- Empower Pharmacy is one of the largest compounding pharmacies in the US with a broad peptide formulary. FDA-registered 503A/503B facility with direct-to-patient fulfillment.
- Olympia Pharmacy is an FDA-registered 503B outsourcing facility known for peptide therapy formulations and quality documentation.
- Strive Pharmacy specializes in personalized compounding for weight loss and hormone therapy, including peptide formulations.
- Belmar Pharma Solutions is a national compounding pharmacy with expertise in BHRT, TRT, and specialty compounds including peptides.
- BoomRx is a pharmacy fulfillment platform with a multi-pharmacy network, giving practices access to multiple compounding sources from a single interface.
Setting Up Patient Intake and Clinical Workflows
A well-structured workflow is what separates a profitable peptide program from a chaotic one. Here is what you need to build:
Patient Intake
Your intake process should capture everything the prescribing physician needs to make a clinical decision:
- Medical history including current conditions, past surgeries, and hospitalizations
- Current medications to screen for drug interactions
- Allergies including any history of reaction to injectable medications
- Treatment goals so the physician understands what the patient is looking for
- Contraindication screening questions specific to peptide therapy (pregnancy, active cancer, bleeding disorders)
- Informed consent covering the off-label nature of many peptide applications, potential side effects, and the patient’s right to decline
Intake forms should be digital, HIPAA-compliant, and ideally embedded on your practice’s website under your brand. This creates a smooth patient experience and keeps the workflow within a single system.
Clinical Review and Prescribing
Once a patient completes intake, the clinical review process should be structured and efficient:
- AI-assisted screening flags contraindications, summarizes medical history, and prepares a clinical summary for physician review
- Physician review of the clinical summary, intake data, and any lab results
- Clinical decision to approve, request additional information, or decline
- Prescription creation with appropriate peptide, dosing, route of administration, and treatment duration
- Pharmacy routing to send the prescription directly to the compounding pharmacy
The goal is to minimize the physician’s time on administrative tasks while maintaining full clinical control. AI-assisted clinical review can reduce the per-patient review time from 15 to 20 minutes down to 5 minutes or less.
Follow-Up and Monitoring
Peptide therapy patients require ongoing monitoring:
- Check-in schedules at 2 weeks, 4 weeks, and then monthly depending on the protocol
- Treatment adjustments based on patient response and any side effects
- Refill management to ensure patients stay on protocol without gaps
- Reactivation outreach for patients who fall off their treatment schedule
Automated follow-up systems handle much of this. Treatment reminders, check-in prompts, and reactivation campaigns can run automatically, keeping patients engaged without requiring manual outreach from your team.
Compliance and Regulatory Considerations
Peptide therapy sits at the intersection of compounding law, state prescribing regulations, and evolving FDA policy. Getting compliance right is not optional.
Federal Regulatory Status
The FDA categorizes bulk drug substances for compounding eligibility. Category 1 substances can be compounded; Category 2 substances cannot. As of May 2026, approximately 14 peptides are expected to move from Category 2 back to Category 1 based on the February 2026 HHS announcement. The formal rule has not yet been published.
Before prescribing any peptide, verify its current FDA category status on the FDA’s compounding page.
State-Level Requirements
Peptide prescribing regulations vary by state. Check with your state medical board on:
- Prescriptive authority for compounded medications
- Telehealth prescribing rules if you plan to offer virtual consultations
- Any state-specific compounding regulations
- Documentation and record-keeping requirements
Informed Consent
Your informed consent for peptide therapy should clearly state that:
- Many peptide applications are used off-label and are not FDA-approved for the specific condition being treated
- Potential side effects specific to the prescribed peptide
- The expected treatment timeline and what results to anticipate
- The patient’s right to decline treatment or discontinue at any time
Malpractice Coverage
Contact your malpractice insurance provider before launching. Confirm that your policy covers prescribing compounded peptides and any telehealth consultations you plan to offer. Some carriers require a rider or have specific documentation requirements.
Marketing Your Peptide Program to Patients
A peptide program with no patients is just a cost center. Here is how to generate patient demand.
Your Practice Website
Your website is the foundation. You need:
- A dedicated peptide therapy page explaining what you offer, which peptides are available, and what patients can expect
- Patient intake forms embedded directly on the page
- Clear calls to action to schedule a consultation or fill out an intake form
- Educational content about specific peptides (this builds SEO authority and attracts organic traffic)
Patient Education
Patients searching for peptide therapy are typically more educated and research-oriented than average. Create content that speaks to them:
- Blog posts explaining specific peptides and their uses
- FAQ pages addressing common questions about peptide therapy
- Educational emails for your existing patient list
Existing Patient Base
Your current patients are your easiest conversion opportunity. If you already have patients coming in for other services, peptide therapy is a natural upsell:
- Email your existing patients about your new peptide program
- Mention peptide therapy during relevant appointments
- Create referral incentives for patients who send friends and family
Local SEO
Optimize for local search terms like “peptide therapy [your city]” and “BPC-157 prescriber near me.” Google Business Profile, local citations, and location-specific website content help you appear in local search results.
How Karpa Health Supports Your Peptide Program
Karpa Health handles the operational infrastructure so you can focus on clinical care. The platform includes:
- White-label patient intake that embeds on your practice website under your brand
- AI-powered clinical review that screens patients, flags contraindications, and prepares clinical summaries
- One-click prescribing to integrated compounding pharmacies including Empower, Olympia, Strive, Belmar, and BoomRx
- Real-time order tracking and direct-to-patient fulfillment
- Automated patient follow-up with treatment reminders and reactivation campaigns
- Built-in telehealth video conferencing and calendar scheduling
The platform also supports GLP-1 weight loss, TRT, and HRT programs, so you can launch multiple cash-pay programs from a single system.
Learn more about Karpa’s peptide therapy platform or book a demo to see how it works.